Details for 2018702299

Up to date per 02.04.2026

Actions

Title / Product Name

KREBSBEHANDLUNG

Status

Granted/Registered

Protection Type

European Patent

(AT-) Application Number

2018702299

EP Publication Number

3576740

E-Number

1578731

Language

PCT Number

EP18052694

Publication Date

11.12.2019 A

14.06.2023 B1

Registration Date

14.06.2023

AT Publication Date

15.07.2023

Application Date

02.02.2018

Registration Number

Priorities

06.02.2017

201762455211 P

20.12.2017

17209098

IPC

A61K 31/498 20060101AFI20180810BHEP

Maximum Duration of Protection

02.02.2038

Owner

Janssen Pharmaceutica NVTurnhoutseweg 30 2340 BeerseBE

Representative

Authorized Recipients

Paul CosmoviciGumpendorfer Straße 1421060 WienAT

Inventor

STUYCKENS, Kimc/o Janssen Pharmaceutica NV Turnhoutseweg 30 2340 BeerseBE

PEREZ RUIXO, Juan, Josec/o Janssen-Cilag, S.A. Edificio Johnson & Johnson Paseo de las Doce Estrellas, 5-7, 5° planta Campo de las Naciones 28042 MadridES

DE PORRE, Peter, Marie, Z.c/o Janssen Pharmaceutica NV Turnhoutseweg 30 2340 BeerseBE

AVADHANI, Anjali, Narayanc/o Janssen Pharmaceuticals Inc. Springhouse Campus 1400 McKean Road Springhouse Pennsylvania 19477US

LORIOT, Yohannc/o Gustave Roussy 114, rue Édouard-Vaillant 94805 Villejuif CedexFR

SIEFKER-RADTKE, Arlene, O.c/o Janssen Pharmaceutica NV Turnhoutseweg 30 2340 BeerseBE

Information about Fees